III. Intracerebral Hemorrhage

Shinohara, Yukito; Yanagihara, Takehiko; Abe, Kōji; Yoshimine, Toshiki; Fujinaka, Toshiyuki; Chuma, Takayo; Ochi, Fumio; Nagayama, Masao; Suzuki, Noriyuki; Katayama, Yasuo; Kimura, Akio; Yasui, Nobuyuki

doi:10.1016/j.jstrokecerebrovasdis.2011.05.005

Cited by 19 publications

(11 citation statements)

References 290 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Patients' background features were generally similar among the studies. Figure 2a shows the change in the NIHSS scores during the initial 72 h. The median NIHSS score was 13 (8)(9)(10)(11)(12)(13)(14)(15)(16)(17) at baseline and 10 (5-15) at 72 h (P < 0.0001). The average absolute change was À2 (À4 to 0).…”

Section: Clinical Outcome Measuresmentioning

confidence: 99%

See 1 more Smart Citation

Systolic blood pressure lowering to 160 mmHg or less using nicardipine in acute intracerebral hemorrhage

Koga

Toyoda²,

Yamagami³

et al. 2012

Journal of Hypertension

View full text Add to dashboard Cite

show abstract

Section: Clinical Outcome Measuresmentioning

confidence: 99%

“…In the Japanese Guidelines for the Management of Stroke 2009, the recommendation for SBP for acute ICH was less than 180 mmHg [16]. The Japanese official label prohibited nicardipine use during hyperacute ICH [17].…”

Section: Introductionmentioning

confidence: 99%

Systolic blood pressure lowering to 160 mmHg or less using nicardipine in acute intracerebral hemorrhage

Koga

Toyoda²,

Yamagami³

et al. 2012

Journal of Hypertension

View full text Add to dashboard Cite

show abstract

“…In Japan, evidence-based comprehensive GLs on cerebrovascular diseases were published in 2004 and 2009 from the Japan Stroke Society, but only in Japanese. In response to the request for the English version, considering the differences in race, stroke types, subtypes and drugs authorized, high morbidity and mortality of cerebrovascular disorders in Asian countries, which exceed those of myocardial infarction, and, also, the vast amount of untranslated Japanese literature, the English version of the entire Japanese GLs were first published in 2011 [1,2,3,4,5,6,7]. The purpose of this article is to compare the latest versions of the European and Japanese GLs for the management of ischemic stroke.…”

mentioning

confidence: 99%

“…We compared the GLs, especially Recommendations of ESO GLs 2008 [8] and the 2009 update [9], with those of the Japanese GLs 2009 (English version in 2011 [1,2,3,4,5,6,7]). We tried to clarify the differences and similarities of both GLs and worked out which recommendations lacked in both GLs.…”

mentioning

confidence: 99%

Comparison of the European and Japanese Guidelines for the Management of Ischemic Stroke

et al. 2013

Self Cite

View full text Add to dashboard Cite

Background: Different aspects of acute stroke management and strategies for stroke prevention derive from two viewpoints: specific traditional and historical backgrounds and evidence-based medicine from modern randomized controlled trials (RCTs), meta-analysis and authorized clinical practice guidelines (GLs). Regarding stroke, GLs have been published by national and international organizations in different languages, most frequently in English. Cerebrovascular Diseases published the European GLs for the management of ischemic stroke and transient ischemic attacks in 2003, with an update in 2008. At about the same time (in 2004), the first Japanese GLs for the management of stroke appeared in Japanese. The first English version of the updated Japanese GLs was published only in 2011 and included differently approved drugs and drug dosages as compared with other American or European countries. Methods: Since 2011, the authors have met repeatedly and have compared the latest versions of published European and Japanese GLs for ischemic and hemorrhagic strokes. Many aspects have only been addressed in one but left out in the other GLs, which consequently founded the basis for the comparison. Classification of evidence levels and recommendation grades defined by the individual committees differed between both original GLs. Results: Aspects of major importance were surprisingly similar and hence did not need extensive interpretation. Other aspects of ischemic stroke management differed significantly, e.g. the dosage of recombinant tissue plasminogen activator approved in Japan is lower (0.6 mg/kg) than in Europe (0.9 mg/kg), which derived from different practices in cardiovascular treatment prior to the design of acute ischemic stroke RCTs. Furthermore, comedication with neuroprotective agents (edaravone), intravenous anticoagulants (argatroban) or antiplatelet agents within 1-2 days after stroke onset is recommended in Japan but not in Europe. For cardioembolic stroke prevention, a major difference consists in a higher international normalized ratio target (2.0-3.0) in younger subjects versus in those >70 years (1.6-2.6), without age restrictions in Europe. Conclusion: This brief survey - when compared with the lengthy original recommendations - provides a stimulating basis for an extended interest among Japanese and European stroke clinicians to learn from their individual experiences and to strengthen efforts for joint cooperation in treating and preventing stroke all around the globe.

show abstract

“…We compared the European Stroke Initiative (EUSI) Recommendations for the management of ICH (2006) [2] and the chapters of ICH in the Japanese guidelines for the management of stroke (2009) [3]. Japanese guidelines are more up to date and thus included trials that were not available when EUSI guidelines were written.…”

mentioning

confidence: 99%

Comparison of the European and Japanese Guidelines for the Acute Management of Intracerebral Hemorrhage

et al. 2013

Self Cite

View full text Add to dashboard Cite

Background: Different aspects of acute stroke management and strategies for stroke prevention derive from two viewpoints: specific traditional and historical backgrounds and evidence-based medicine from modern randomized controlled trials (RCTs), meta-analysis and authorized clinical practice guidelines (GLs). Regarding intracerebral hemorrhage (ICH), Cerebrovascular Diseases published the 2006 European stroke initiative recommendations for the management of ICH. In 2009, the revised Japanese GLs for the management of stroke, including that of ICH, appeared in Japanese. Whereas GLs for the prevention and treatment of ischemic stroke were presented in detail, recommendations with regard to ICH are relatively rare both in Japan and Europe. Methods: Since 2011, the authors have met repeatedly and have compared the latest versions of published European and Japanese GLs for ischemic and hemorrhagic strokes. Many aspects have only been addressed in one but left out in the other GLs, which consequently founded the basis for the comparison. Classification of evidence levels and recommendation grades defined by the individual committees differed between both original GLs. Results: Aspects of major importance were similar and hence did not need extensive interpretation, mostly due to a lack of evidence from appropriate RCTs worldwide. The target level to which systolic blood pressure should be lowered is quite high; <170 mm Hg for patients with known hypertension in Europe and <180 mm Hg in Japan. The results of ongoing clinical trials are awaited for the optimal target level and optimal medications. Concerning ICH associated with oral anticoagulant therapy, both guidelines give similar recommendations, namely that anticoagulation should be discontinued and the international normalized ratio of prothrombin time should be normalized with prothrombin complex concentrate or fresh-frozen plasma and additional vitamin K. Patients with ICH were treated surgically, often based on individual decisions - more frequently in Japan, depending on the association with hypertension. Patients with large or intraventricular bleedings were only treated if a life-saving performance was considered, irrespective of the neurological outcome. Infra- and supratentorial differences were similarly addressed in both GLs. Conclusion: This brief survey - when compared with the lengthy original recommendations - provides a stimulating basis for an extended interest among Japanese and European stroke clinicians to learn from their individual experiences and to strengthen efforts for joint cooperation in treating and preventing stroke all around the globe.

show abstract

III. Intracerebral Hemorrhage

Cited by 19 publications

References 290 publications

Systolic blood pressure lowering to 160 mmHg or less using nicardipine in acute intracerebral hemorrhage

Systolic blood pressure lowering to 160 mmHg or less using nicardipine in acute intracerebral hemorrhage

Comparison of the European and Japanese Guidelines for the Management of Ischemic Stroke

Comparison of the European and Japanese Guidelines for the Acute Management of Intracerebral Hemorrhage

Contact Info

Product

Resources

About